Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Flupirtine

Flupirtine

Flupirtine structure

Flupirtine 

structure
  • CAS No:

    56995-20-1

  • Formula:

    C15H17FN4O2

  • Chemical Name:

    Flupirtine

  • Synonyms:

    Carbamic acid,N-[2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-,ethyl ester;Carbamic acid,[2-amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]-,ethyl ester;Flupirtine;Katadolon;D 9998;Trancopal Dolo;Ethyl [2-Amino-6-[(4-fluorobenzyl)amino]pyridin-3-yl]carbamate;[2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester

  • Categories:

    Organic Chemistry  >  Amides

Description

N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester is an aminopyridine.|Flupirtine is a pyridine derivative that is in clinical use as a nonopioid analgesic. It was approved for the treatment of pain in 1984 in Europe. It is not approved for use in the U.S. or Canada, but is currently in phase II trials for the treatment of fibromyalgia.

Flupirtine Basic Attributes

304.32

304.13355396

260-503-8

MOH3ET196H

DTXSID4048436

N - Nervous system

Characteristics

115.5 °C

Safety Information

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P301+P312, P304+P312, P304+P340, P312, P330, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Toxicity

Oral, mouse: LD50 = 300 mg/kg; Oral, rabbit: LD50 = 3200 mg/kg; Oral, rat: LD50 = 980 mg/kg.

Drug Information

Investigated for use/treatment in fibromyalgia.

Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)

Bioavailability: 90% (oral), 70% (rectal)|72% of flupirtine and its metabolites appear in urine and 18% appear in faeces.

Hepatic to 2-amino-3-acetylamino-6-(para-fluorobenzylamino) pyridine (which has 20-30% the analgesic potential of its parent compound) and Para-fluorohippuric acid.

6.5 hrs (average), 11.2-16.8 hrs (average 14 hrs) (elderly), 8.7-10.9 hrs (average 9.8 hrs) (in those with moderate-level renal impairment).

Flupirtine upregulates Bcl-2, increases glutathione levels, activates an inwardly rectifying potassium channel, and delays loss of intermitochondrial membrane calcium retention capacity. Flupirtine acts like a NMDA receptor antagonists, but does not bind to the receptor. One study concluded that the discriminative effects of flupirtine are neither of opioid nor of alpha-1 adrenergic type, but are primarily mediated through alpha-2 adrenergic mechanisms [PMID: 2901483].

D 9998

Flupirtine Use and Manufacturing

Pharmaceuticals

Computed Properties

Molecular Weight:304.32
XLogP3:2.4
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:6
Exact Mass:304.13355396
Monoisotopic Mass:304.13355396
Topological Polar Surface Area:89.3
Heavy Atom Count:22
Complexity:350
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.